Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antibody response to a new member of the DBL family (EBP2) after a brief Plasmodium vivax exposure

PLoS neglected tropical diseases(2022)10.1371/journal.pntd.0010493Source: DataRank Database

Antibody response to a new member of the DBL family (EBP2) after a brief Plasmodium vivax exposure is a research paper published in PLoS neglected tropical diseases (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.78)OA: goldTopics (54)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Gabriela M. Fernandes,Leticia M. Torres‐Martínez ORCID,Camilla Valente Pires ORCID,Jéssica R. S. Alves,Sâmick L. Moreira-Nascimento

Live enrichment

PubMed:35714097 PMC:PMC9205486 OpenAlex:https://openalex.org/W4283031128

Fundação Oswaldo Cruz

Grant: 8571634294

National Institutes of Health

Grant: 2R01AI064478-12A1

Immunological characterization of the P. vivax DBP

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior–CAPES

Grant: Finance Code 001

NIAID NIH HHS

Grant: R01 AI064478

Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Conselho Nacional de Desenvolvimento Científico e Tecnológico

FWCI

0.78

Citation Percentile

0.7%

Citation Trend

2023

2024

goldLicense: cc-by

journalhttps://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0010493&type=printable

publisherhttps://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0010493&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pntd.0010493

journalhttps://doi.org/10.1371/journal.pntd.0010493

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35714097

Fields of Study

Malaria Research and ControlComplement system in diseasesMosquito-borne diseases and control0301 basic medicine0303 health sciences03 medical and health sciencesAntibodies, ProtozoanAntibody FormationAntigens, ProtozoanCross-Sectional StudiesHumansImmunoglobulin GImmunoglobulin MMalariaMalaria, VivaxPlasmodium vivaxProtozoan ProteinsReceptors, Cell Surface

MeSH Terms

Antibodies, ProtozoanAntibody FormationAntigens, ProtozoanCross-Sectional StudiesHumansImmunoglobulin GImmunoglobulin MMalariaPlasmodium vivaxReceptors, Cell SurfaceProtozoan ProteinsMalaria, Vivax

Keywords

Plasmodium vivaxAntibodyVirologyMalariaBiologyImmunogenicityImmunologyOutbreakImmunoglobulin GPlasmodium falciparumRC955-962Protozoan ProteinsAntibodies, ProtozoanAntigens, ProtozoanReceptors, Cell SurfaceCross-Sectional StudiesImmunoglobulin MArctic medicine. Tropical medicineAntibody FormationMalaria, VivaxHumansPublic aspects of medicineRA1-1270Research Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Antibody response to a new member of the DBL family (EBP2) after a brief Plasmodium vivax exposure

FAIR Checklist

Authors (16)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)